Dr. Reddy's Buys Italian Marketing firm

Ramesh, Deepti
April 2008
Chemical Week;4/14/2008, Vol. 170 Issue 12, p33
Trade Publication
The article reports on the announcement made by pharmaceutical firm Dr. Reddy's Laboratories of Hyderabad, India that it has acquired Jet Generici Srl of Italy. Financial terms were not disclosed. The acquisition provides access to an essential product portfolio, a pipeline of registration applications, and a sales and marketing organization.


Related Articles

  • Reddy-ly establishing a European presence.  // Pharmaceutical Technology Europe;May2008, Vol. 20 Issue 5, p9 

    The article focuses on the significance of the two European acquisitions of Dr. Reddy's Laboratories Ltd. to its generic pipeline and research and development (R&D) infrastructure. The author claims that the acquisitions could result in cheaper medicines produced by the pharmaceutical company....

  • April March. Sharma, E. Kumar // Business Today;6/1/2008, Vol. 17 Issue 11, p38 

    The article reports on the acquisitions made by Dr Reddy's Laboratories in April 2008. Dr Reddy's Laboratories announced its decision to acquire a portion of Dowpharma Small Molecules Business from Dow Chemical Co. in April 1, 2008. Two days later, the company revealed its takeover of Jet...

  • Dr Reddy's Inks commercialisation Deal with Hatchtech.  // eHEALTH;9/16/2015, p1 

    The article reports on the commercialization contract signed by pharmaceutical company Dr. Reddy's Laboratories Ltd. with Australian pharmaceutical company Hatchtech Pty. Ltd., for the development of an innovative prescription head lice product Xeglyze lotion.

  • Dr. Reddy's Unveils Logo.  // Chain Drug Review;8/10/2015, Vol. 37 Issue 12, p74 

    The article offers information on the new visual brand and identity launched by pharmaceutical firm Dr. Reddy's Laboratories Ltd. worldwide.

  • DRL to acquire BMS Laboratories and Meridian Healthcare UK.  // Pharmaceutical Technology Asia;Aug2002, p7 

    Focuses on an agreement signed by Dr Reddy's Laboratories (DRL) to acquire BMS Laboratories Limited and Meridian Healthcare. Impact of the agreement on the expansion efforts of DRL.

  • Beyond betapharm. Sharma, E. Kumar // Business Today;3/21/2010, Vol. 19 Issue 6, p90 

    The article focuses on the emergence of problems after the acquisition of German generics company betapharm Arzneimittel GmbH by Indian pharmaceutical company Dr. Reddy's Laboratories Ltd. It notes that the German government introduced healthcare sector reforms which converted branded generics...

  • OctoPlus Shares Surge After Dr. Reddy's $36M Buyout Bid. Sheridan, Cormac // BioWorld Today;10/23/2012, Vol. 23 Issue 206, p2 

    The article reports on the 27.4 million euro-cash buyout offer accepted by OctoPlus NV from Dr. Reddy's Laboratories Ltd. The event has pushed OctoPlus share price up by 23 percent. Dr. Reddy's is now planning to proceed with a recommended public offer for all the outstanding shares of OctoPlus....

  • Dr Reddy's ready to drive down costs. Cameron, Amanda // New Zealand Doctor;9/24/2008, p35 

    The article features Affordable Healthcare, a New Zealand company acquired by Indian generics manufacturer Dr. Reddy in April 2008. Affordable Healthcare was created in 2003 as a distributor of Dr. Reddy's products and was later set-up for acquisition by Dr. Reddy. Affordable Healthcare won the...

  • Indian Firm Buys Roche API Business Unit in Mexico. Scott, Alex // Chemical Week;11/23/2005, Vol. 167 Issue 40, p25 

    The article reports on the agreement of Dr. Reddy's Laboratories (DRL), a producer of drugs and active pharmaceutical ingredients (API), to acquire Roche's API manufacturing business at Cuernavaca, Mexico. The acquisition deal includes all existing business supply contracts, including ongoing...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics